Quality Packaging Specialists International, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2030 Route 130 N, Burlington, New Jersey (NJ) 08016, United States (USA)
- Operations here
- analysislabelmanufacturepackrelabelrepack
- FDA identifiers
- FEI 1000208912 · DUNS 825078165
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-05-12
- NAIDrug Quality Assurance2017-11-03
- NAIDrug Quality Assurance2015-12-17
- NAIDrug Quality Assurance2013-02-27
- NAIDrug Quality Assurance2011-03-17
- NAIDrug Quality Assurance2009-09-24
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- gadobutrolBayer HealthCare Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.